Skip to content

To study the effect of oxygen therapy given at very high rate in patient with sudden onset of breathing failure.

High-Flow Oxygen Through Nasal Cannula In Acute Hypoxemic Respiratory Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/09/015717
Enrollment
140
Registered
2018-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J960- Acute respiratory failure

Interventions

Intervention1: High-flow oxygen therapy: Oxygen supply through a heated humidifier,Fisher & Paykel, with large-bore binasal cannula, with a gas flow rate of 60 liters per minute Control Intervention1

Sponsors

Tata Memorial Center
Lead Sponsor
Not Any
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18year and above 2.Respiratory rate of >25 breaths per minute 3.Ratio of the partial pressure of arterial oxygen (PaO2) to the fractional oxygen (FiO2) of 300 mm Hg or less while the patient breathing oxygen with oxygen analyzer in situ at a flow rate of 10 liters per minute for at least 15 minutes

Exclusion criteria

Exclusion criteria: 1.The main exclusion criteria is PaCo2 >45 mm Hg, 2.Exacerbation of asthma or chronic respiratory failure, 3.Cardiogenic pulmonary edema, 4.A history of underlying chronic respiratory disease 5.Hemodynamic instability, use of vasopressors in a dose more than 0.25mcg/kg/min, 6.Glasgow Coma Scale score of 12 points or less 7.Contraindications to NIV 8.Urgent need for endotracheal intubation, 9.Palliative patients 10.Tracheostomy 11.Likelihood of Survival 12.Patient with respiratory failure due to potentially irreversible causes e.g. Post radiotherapy fibrosis, Progression of Lung diseases etc

Design outcomes

Primary

MeasureTime frame
No of patients that will require endotracheal intubationTimepoint: between day 1 to 28 days after randomization

Secondary

MeasureTime frame
1 Number of ventilator free days (i.e., days alive and without invasive mechanical ventilation)Timepoint: between day 1 to day 28 after randomization;2 Mortality in the ICUTimepoint: at day 90 after randomization;3 Intubation rate in those with P/F ratios below 200Timepoint: between day 1 to day 28 after randomization;4 Intubation rate in neutropenic patientsTimepoint: between day 1 to day 28 after randomization;5 Total duration of ICU staysTimepoint: between day 1 to day 28 after randomization;6 Complication rates (e.g septic shock, nosocomial pneumonia, cardiac arrhythmia, and cardiac arrestTimepoint: between day 1 to day 28 after randomization;7 Grade of dyspneaTimepoint: between day 1 to day 28 after randomization

Countries

India

Contacts

Public ContactDr Sheila Nainan Myatra

Tata Memorial Center

sheila150@hotmail.com09820156070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026